Skip to main content

3 Reasons PPLI is Risky and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PPLI Cover Image

People has been treading water for the past six months, holding steady at $40.94. The stock also fell short of the S&P 500’s 14.3% gain during that period.

Is there a buying opportunity in People, or does it present a risk to your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free.

Why Do We Think People Will Underperform?

We’re passing on People for now. Here are three reasons we avoid PPLI, plus one stock we’d rather own.

1. Revenue Spiraling Downwards

Examining a company’s long-term performance can provide clues about its quality. Any business can have short-term success, but a top-tier one grows for years. Over the last five years, People’s demand was weak and its revenue declined by 8% per year. This was below our standards and signals it’s a low quality business.

People Quarterly Revenue

2. EPS Trending Down

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Sadly for People, its EPS declined by 18.6% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.

People Trailing 12-Month EPS (Non-GAAP)

3. Breakeven Free Cash Flow Limits Reinvestment Potential

Free cash flow isn’t a prominently featured metric in company financials and earnings releases, but we think it’s telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

People broke even from a free cash flow perspective over the last five years, giving the company limited opportunities to return capital to shareholders.

People Trailing 12-Month Free Cash Flow Margin

Final Judgment

People doesn’t pass our quality test. With its shares underperforming the market lately, the stock trades at 15.2× forward P/E (or $40.94 per share). At this valuation, there’s a lot of good news priced in - we think there are better opportunities elsewhere. We’d suggest looking at one of Charlie Munger’s all-time favorite businesses.

Stocks We Like More Than People

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  261.49
+7.43 (2.92%)
AAPL  334.71
-5.71 (-1.68%)
AMD  609.55
-11.13 (-1.79%)
BAC  54.02
+0.41 (0.77%)
GOOG  350.70
+5.84 (1.69%)
META  724.65
+3.76 (0.52%)
MSFT  535.11
+12.50 (2.39%)
NVDA  229.67
-0.81 (-0.35%)
ORCL  141.93
+6.74 (4.98%)
TSLA  383.36
+8.36 (2.23%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.